Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - NYSE:IMAX - CA45245E1097 - Common Stock

32.06 USD
+0.01 (+0.03%)
Last: 10/22/2025, 8:04:00 PM
33 USD
+0.94 (+2.93%)
Pre-Market: 10/23/2025, 8:15:36 AM
Fundamental Rating

5

Overall IMAX gets a fundamental rating of 5 out of 10. We evaluated IMAX against 80 industry peers in the Entertainment industry. IMAX has an average financial health and profitability rating. IMAX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
IMAX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

The Return On Assets of IMAX (3.77%) is better than 76.25% of its industry peers.
IMAX has a better Return On Equity (10.23%) than 76.25% of its industry peers.
IMAX has a Return On Invested Capital of 6.88%. This is in the better half of the industry: IMAX outperforms 78.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMAX is significantly below the industry average of 9.23%.
The last Return On Invested Capital (6.88%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROIC 6.88%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin of IMAX (9.04%) is better than 82.50% of its industry peers.
In the last couple of years the Profit Margin of IMAX has declined.
IMAX has a better Operating Margin (18.00%) than 91.25% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
The Gross Margin of IMAX (56.88%) is better than 66.25% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18%
PM (TTM) 9.04%
GM 56.88%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAX is destroying value.
The number of shares outstanding for IMAX has been reduced compared to 1 year ago.
The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
Compared to 1 year ago, IMAX has a worse debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 2.35. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
IMAX has a Altman-Z score of 2.35. This is in the better half of the industry: IMAX outperforms 66.25% of its industry peers.
IMAX has a debt to FCF ratio of 4.75. This is a neutral value as IMAX would need 4.75 years to pay back of all of its debts.
IMAX has a Debt to FCF ratio of 4.75. This is in the better half of the industry: IMAX outperforms 65.00% of its industry peers.
IMAX has a Debt/Equity ratio of 0.87. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
IMAX has a worse Debt to Equity ratio (0.87) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Altman-Z 2.35
ROIC/WACC0.97
WACC7.06%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IMAX has a Current Ratio of 2.33. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMAX (2.33) is better than 76.25% of its industry peers.
A Quick Ratio of 2.02 indicates that IMAX has no problem at all paying its short term obligations.
IMAX's Quick ratio of 2.02 is fine compared to the rest of the industry. IMAX outperforms 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 2.02
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

IMAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.82%, which is quite good.
Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
The Revenue has been growing slightly by 1.25% in the past year.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%

3.2 Future

The Earnings Per Share is expected to grow by 24.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.79% on average per year.
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue Next Year11.5%
Revenue Next 2Y8.73%
Revenue Next 3Y6.79%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.74, IMAX can be considered very expensive at the moment.
75.00% of the companies in the same industry are more expensive than IMAX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IMAX to the average of the S&P500 Index (27.57), we can say IMAX is valued inline with the index average.
IMAX is valuated rather expensively with a Price/Forward Earnings ratio of 21.18.
81.25% of the companies in the same industry are more expensive than IMAX, based on the Price/Forward Earnings ratio.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.74
Fwd PE 21.18
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than 67.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than 76.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.44
EV/EBITDA 15.13
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 18.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y26.22%
EPS Next 3Y18.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAX CORP

NYSE:IMAX (10/22/2025, 8:04:00 PM)

Premarket: 33 +0.94 (+2.93%)

32.06

+0.01 (+0.03%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners90.65%
Inst Owner Change-0.23%
Ins Owners19.38%
Ins Owner Change-0.54%
Market Cap1.72B
Revenue(TTM)362.48M
Net Income(TTM)32.78M
Analysts80
Price Target35.33 (10.2%)
Short Float %14.04%
Short Ratio5.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.07%
Min EPS beat(2)11.91%
Max EPS beat(2)20.24%
EPS beat(4)3
Avg EPS beat(4)19.46%
Min EPS beat(4)-6.42%
Max EPS beat(4)52.13%
EPS beat(8)7
Avg EPS beat(8)69.57%
EPS beat(12)9
Avg EPS beat(12)28.75%
EPS beat(16)11
Avg EPS beat(16)16.57%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)1.04%
Revenue beat(4)1
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)6
Avg Revenue beat(12)1.29%
Revenue beat(16)7
Avg Revenue beat(16)2.04%
PT rev (1m)2.42%
PT rev (3m)9.17%
EPS NQ rev (1m)7.51%
EPS NQ rev (3m)4.77%
EPS NY rev (1m)0%
EPS NY rev (3m)8.34%
Revenue NQ rev (1m)3.91%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 31.74
Fwd PE 21.18
P/S 4.76
P/FCF 29.44
P/OCF 22.41
P/B 5.38
P/tB 7.73
EV/EBITDA 15.13
EPS(TTM)1.01
EY3.15%
EPS(NY)1.51
Fwd EY4.72%
FCF(TTM)1.09
FCFY3.4%
OCF(TTM)1.43
OCFY4.46%
SpS6.74
BVpS5.96
TBVpS4.15
PEG (NY)0.96
PEG (5Y)N/A
Graham Number11.64
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROCE 8.68%
ROIC 6.88%
ROICexc 8.05%
ROICexgc 11.79%
OM 18%
PM (TTM) 9.04%
GM 56.88%
FCFM 16.16%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Debt/EBITDA 2.22
Cap/Depr 30.7%
Cap/Sales 5.07%
Interest Coverage 250
Cash Conversion 61.51%
Profit Quality 178.66%
Current Ratio 2.33
Quick Ratio 2.02
Altman-Z 2.35
F-Score7
WACC7.06%
ROIC/WACC0.97
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%
Revenue Next Year11.5%
Revenue Next 2Y8.73%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
EBIT growth 1Y52.22%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year238.45%
EBIT Next 3Y52.46%
EBIT Next 5Y33.94%
FCF growth 1Y63.61%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y58.66%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%